Article
Outcomes and Burdens to Return-to-Play for Phenotype Negative Athletes With a Genetic Heart Disease.
JACC. Clinical electrophysiology - 1 Aug 2025
Martinez Katherine A, Bos J Martijn, Tobert Kathryn E, Giudicessi John R, Ackerman Michael J
Abstract excerpt
BACKGROUND: Over the past decade, the care of athletes with a genetic heart disease (GHD) has shifted. Guidelines surrounding return-to-play (RTP) for athletes who are genotype positive but phenotype negative (G+/P-) remain variable and their management challenging. Recommendations depend on diagnosis, ranging from RTP with monitoring [hypertrophic cardiomyopathy (HCM), and long QT syndrome (LQTS)] to automatic...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
